Hepatocyte growth factor in kidney fibrosis: therapeutic potential and mechanisms of action.
about
Biology of MET: a double life between normal tissue repair and tumor progressionBeta-cell-specific ablation of the hepatocyte growth factor receptor results in reduced islet size, impaired insulin secretion, and glucose intoleranceClinical-Grade Isolated Human Kidney Perivascular Stromal Cells as an Organotypic Cell Source for Kidney Regenerative Medicine.Emerging molecular targets in oncology: clinical potential of MET/hepatocyte growth-factor inhibitors.Renal fibrosis.Medical therapy of stricturing Crohn's disease: what the gut can learn from other organs - a systematic review.Ochratoxin A-induced renal cortex fibrosis and epithelial-to-mesenchymal transition: molecular mechanisms of ochratoxin A-injury and potential effects of red wine.Hepatocyte growth factor, a determinant of airspace homeostasis in the murine lung.Hepatocyte growth factor signaling ameliorates podocyte injury and proteinuria.Loss of TGF-beta type II receptor in fibroblasts promotes mammary carcinoma growth and invasion through upregulation of TGF-alpha-, MSP- and HGF-mediated signaling networksDiminished met signaling in podocytes contributes to the development of podocytopenia in transplant glomerulopathyHepatocyte growth factor receptor signaling mediates the anti-fibrotic action of 9-cis-retinoic acid in glomerular mesangial cells.Hepatocyte growth factor attenuates liver fibrosis induced by bile duct ligationDysfunction of fibroblasts of extrarenal origin underlies renal fibrosis and renal anemia in miceConditioned mesenchymal stem cells attenuate progression of chronic kidney disease through inhibition of epithelial-to-mesenchymal transition and immune modulation.hepatocyte growth factor is a downstream effector that mediates the antifibrotic action of peroxisome proliferator-activated receptor-gamma agonists.Distinctive role of Stat3 and Erk-1/2 activation in mediating interferon-gamma inhibition of TGF-beta1 action.Cellular and molecular mechanisms of renal fibrosis.New insights into epithelial-mesenchymal transition in kidney fibrosis.Fibrosis in the kidney: is a problem shared a problem halved?Differential expression of wound fibrotic factors between facial and trunk dermal fibroblasts.Pharmacological management of renal fibrotic disease.Mechanisms of disease: Fibroblasts--a new look at an old problem.Deleting the TGF-β receptor in proximal tubules impairs HGF signalingAngiogenic cytokines in renovascular disease: do they have potential for therapeutic use?Hepatocyte growth factor exerts its anti-inflammatory action by disrupting nuclear factor-kappaB signalingTherapeutic potential of TGF-beta inhibition in chronic renal failure.Role of Bcl-xL induction in HGF-mediated renal epithelial cell survival after oxidant stress.Cardiac and renal protective effects of irbesartan via peroxisome proliferator-activated receptorγ-hepatocyte growth factor pathway independent of angiotensin II Type 1a receptor blockade in mouse model of salt-sensitive hypertensionParicalcitol inhibits renal inflammation by promoting vitamin D receptor-mediated sequestration of NF-kappaB signalingMacrophage diversity in renal injury and repair.Human Wharton's jelly-derived mesenchymal stromal cells reduce renal fibrosis through induction of native and foreign hepatocyte growth factor synthesis in injured tubular epithelial cells.Novel actions of tissue-type plasminogen activator in chronic kidney disease.Activation of hepatocyte growth factor receptor, c-met, in renal tubules is required for renoprotection after acute kidney injury.Therapeutic role and potential mechanisms of active Vitamin D in renal interstitial fibrosisAstragalus mongholicus ameliorates renal fibrosis by modulating HGF and TGF-beta in rats with unilateral ureteral obstruction.The complement factor 5a receptor 1 has a pathogenic role in chronic inflammation and renal fibrosis in a murine model of chronic pyelonephritisKidney Tissue Targeted Metabolic Profiling of Unilateral Ureteral Obstruction Rats by NMRTGF-beta signal transduction in chronic kidney diseaseFibrogenesis in kidney transplantation: potential targets for prevention and therapy.
P2860
Q28085247-97A434D1-D205-4184-BC99-AD74C4E16F5DQ28506581-F7EB0E0C-4AFA-4D01-81B0-59AA43EB6214Q33722487-F8A0ACC2-FB58-4988-8C6B-8DEA6B6C0415Q33769437-712C9B5A-481A-4F1B-ACD7-7BEBD14E8A31Q34417331-8F0479EB-6FFF-4242-BA08-B584876B23F0Q34504710-EDB2E70C-6DD8-41DB-B607-6F4FA853C452Q34572311-479FBD07-EC00-4064-ACEE-4CA73F82AA7AQ34607913-43587F85-2A84-4FE5-AB24-6D607542F4F8Q34766590-95E600C9-DF44-4323-A017-EFD4E3C69EABQ34781947-19DA2F14-CC81-4E86-9FA5-FEF9ABD13919Q34839515-E7E0FC47-E8AF-45A0-A9A4-E0F55C8E9971Q35085257-8F656577-F3B7-4E1B-8E0E-20A167AEAF17Q35088302-4D092046-5C4E-4268-9891-3F4CE7EC1D58Q35370181-C45452A9-71FF-4E7E-BF70-21117986712EQ35370283-A7FF0457-7D16-4DB1-A572-D6B76DBF983CQ35677086-68DBA08A-099F-43CE-A12F-666FB42BCBFAQ35677699-BFA7CF67-8477-44D2-BADA-1B4772738A99Q35903772-3ECD5264-20D4-4065-81EF-7BDD4553ED4EQ36010095-CECB3137-D70B-41AF-91B5-11495674973CQ36012555-31C25B81-B99D-4A32-9069-40B1F88ECA32Q36353247-579CA5BD-70FE-41D0-A621-959E7CD44EE8Q36407348-59D698BB-3193-416E-B06B-5E9FF97A2C3DQ36577128-2D75B105-F9B7-4CDC-889F-341B7969366BQ36698746-772313C4-C4A4-4FA1-9B71-FD5A47691926Q36707530-AE3BFBFC-78EB-4251-9BC9-9DA3699623ACQ36734848-4C0DB589-AEF4-4F98-B6DA-A88457D98C9DQ36739752-EB2EB825-C209-46A3-9B66-650D16FA980AQ36784932-770FD5B5-5046-4BDA-B5A5-E86F99E919CBQ36824736-738AC988-6E44-4B67-AEF6-17543875BFF2Q36842418-0BB98138-B9F8-46CA-92F7-0271DAF1D1B2Q36955562-A2DA6D89-C0B6-47DC-9261-552F31D9A547Q36998033-09811F48-C110-4167-BFF5-18D048AFC37CQ37115034-AA9BF168-6A3F-4DC9-AB08-F538920D6A9BQ37136339-8A6817EB-220C-426F-AC59-AF86039BA145Q37141825-3A7581BC-A17B-43A8-AA68-9012A8647756Q37177479-2C4537E4-CB3B-45AD-B463-94933348FD00Q37201208-DE34EA63-5024-4402-B0B5-77FBFB15F443Q37257132-7FEF2009-FA53-474D-8FDD-4C979C17AC31Q37410310-A9A90C77-0CBA-4A7F-9870-F9FC93800952Q37638064-28BB8B2B-8A58-4AA9-AE4A-C14CF5F68385
P2860
Hepatocyte growth factor in kidney fibrosis: therapeutic potential and mechanisms of action.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
2004年论文
@zh
2004年论文
@zh-cn
name
Hepatocyte growth factor in ki ...... tial and mechanisms of action.
@ast
Hepatocyte growth factor in ki ...... tial and mechanisms of action.
@en
type
label
Hepatocyte growth factor in ki ...... tial and mechanisms of action.
@ast
Hepatocyte growth factor in ki ...... tial and mechanisms of action.
@en
prefLabel
Hepatocyte growth factor in ki ...... tial and mechanisms of action.
@ast
Hepatocyte growth factor in ki ...... tial and mechanisms of action.
@en
P2860
P1476
Hepatocyte growth factor in ki ...... tial and mechanisms of action.
@en
P2093
Youhua Liu
P2860
P356
10.1152/AJPRENAL.00451.2003
P577
2004-07-01T00:00:00Z